Drug Details
General Information of the Drug (ID: DR8070) | ||||
---|---|---|---|---|
Name |
S-1
|
|||
Synonyms |
Fluoropyrimidine anticancer agent
Click to Show/Hide
|
|||
Disease | Gastrointestinal stromal tumor [ICD-11: 2B5B] | Phase 3 | [1] |
Combinatorial Therapeutic Effect(s) Validated Clinically or Experimentally | ||||||
---|---|---|---|---|---|---|
α. A List of Natural Product(s) Able to Enhance the Efficacy of This Drug | ||||||
Cepharanthine | Stephania delavayi | Click to Show/Hide the Molecular Data of This NP | ||||
Augmenting Drug Sensitivity | Click to Show/Hide | |||||
Representative Experiment Reporting the Effect of This Combination | [2] | |||||
Detail(s) | Combination Info click to show the detail info of this combination | |||||
Molecule(s)
Regulation |
Down-regulation | Expression | DPYD | Molecule Info |
Pathway MAP
|
|
Down-regulation | Expression | TYMS | Molecule Info |
Pathway MAP
|
||
In-vitro Model | HSC-2 | CVCL_1287 | Oral cavity squamous cell carcinoma | Homo sapiens | ||
B88 | Oral squamous cell carcinoma | Homo sapiens | ||||
In-vivo Model | B88 or HSC2 cells (1*106) were suspended in 0.1 mL of serum-free medium and injected into the subcutaneous tissue of 5-week-old nude mice. | |||||
Experimental
Result(s) |
Combined therapy of cepharanthine and S-1 exerted antitumor effects on human OSCC xenografts markedly and significantly induced apoptotic cells in tumors treated with cepharanthine plus S-1. | |||||
Peginterferon alpha 2b | Homo sapiens | Click to Show/Hide the Molecular Data of This NP | ||||
Achieving Therapeutic Synergy | Click to Show/Hide | |||||
Representative Experiment Reporting the Effect of This Combination | [3] | |||||
Detail(s) | Combination Info click to show the detail info of this combination | |||||
Experimental
Result(s) |
Combination therapy with S-1 and PEG-IFN is effective and feasible, and is therefore a promising regimen for advanced HCC. |
Target and Pathway | ||||
---|---|---|---|---|
Target(s) | ATP synthase F(0) complex C1 (ATP5MC1) | Molecule Info | [4] | |
ATP synthase F(0) complex C2 (ATP5MC2) | Molecule Info | [4] | ||
ATP synthase F(0) complex C3 (ATP5MC3) | Molecule Info | [4] |